Ampio Pharmaceuticals Updates On COVID-19 Clinical Trial Activities - Quick Facts

Biopharmaceutical company Ampio Pharmaceuticals, Inc. (AMPE) on Wednesday provided an update regarding the COVID-19 clinical trial activities.

from RTT - Biotech https://ift.tt/2DXwA3L
via IFTTT